| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000000773 |
| Receipt No. | R000000930 |
| Official scientific title of the study | A competitive acetate-free bicarbonate dialysate and standard bicarbonate dialysate of iron metabolism dysregulation improvement and cytokine production chilling of hemodialysis patients : a cross-over multicenter study. |
| Date of disclosure of the study information | 2007/07/30 |
| Last modified on | 2016/08/20 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | A competitive acetate-free bicarbonate dialysate and standard bicarbonate dialysate of iron metabolism dysregulation improvement and cytokine production chilling of hemodialysis patients : a cross-over multicenter study. | |
| Title of the study (Brief title) | Prospective Clinical Cross-over Study of Citrate Containg Dialyzate in hemodialysis patients. (CROCIT study) | |
| Region |
|
|
| Condition | |||
| Condition | Patients, who are treated with maintenance hemodialysis more than one year | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | Examination of iron metabolism improvement and cytokine production chilling in the patients with maintenance hemodialysis by acetate-free bicarbonate dialysate. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | (i) dosages of rHuEPO and iron.
(ii) improvement of QOL . (iii) iron-related index , inflammation, nutrition, oxidative stress, endthelial injury. |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Self control |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | one year in a 4-month cross-over study.
first stage : hemodialysis treatment with standard bicarbonate dialysate. (acetate-containing) second stage: hemodialysis treatment with acetate-free bicarbonate dialysate. (citrate-containing) third stage: hemodialysis treatment with standard bicarbonate. (acetate-containing) |
|
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | (i) Patients with maintenance hemodialysis (age less than 75 years old).
(ii) Patients, whose duration of hemodialysis more than one year, and their hemodynamic state are stable. (iii) Patients, who are received hemodialysis 3 times a week and 4 hours at a time. (iv) Patients with renal anemia, who are treated with rHuEPO or iron. |
|||
| Key exclusion criteria | (i) Patients with chronic inflammation (CRP over 0.3), malignant disorder, severe respiratory organs, and liver disorder.
(ii) Patients, who are recived dialysis treatment except HD such as HF, HDF, and HDF. |
|||
| Target sample size | 30 | |||
| Research contact person | |
| Name of lead principal investigator | Takahiro Kuragano |
| Organization | Hyogo College of Medicine |
| Division name | Internal Medicine (Nephrology and Dialysis) |
| Address | 1-1 Mukokawa-cho, Nisinomiya city, Hyogo, Japan |
| TEL | 0798-45-6111 |
| kuragano@hyo-med.ac.jp | |
| Public contact | |
| Name of contact person | Takahiro Kuragano |
| Organization | Hyogo College of Medicine |
| Division name | Internal Medicine (Nephrology and Dialysis) |
| Address | 1-1 Mukokawa-cho, Nisinomiya city, Hyogo, Japan |
| TEL | 0798-45-6111 |
| Homepage URL | |
| kuragano@hyo-med.ac.jp | |
| Sponsor | |
| Institute | Hyogo College of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Hyogo College of Medicine, Internal Medicine (Nephrology and Dialysis) |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000000930 |